Characterization of CD4+ T cell residency was based on CD69+ expression (30, 31), finding that the majority of CD4+ T cells in primary melanoma are not tumor-resident (CD69+ = 26.5%, CD69- = 72.27%, p = 0.0022, Supplementary Figure 1C). The gene discussed is CD69; the disease is melanoma.